Barriers to medical provider support for prescription naloxone as overdose antidote for lay responders.
about
Resilience, tipping, and hydra effects in public health: emergent collective behavior in two agent-based models.Why is it so hard to implement change? A qualitative examination of barriers and facilitators to distribution of naloxone for overdose prevention in a safety net environment.A Review of Opioid Overdose Prevention and Naloxone Prescribing: Implications for Translating Community Programming Into Clinical Practice.Association between non-fatal opioid overdose and encounters with healthcare and criminal justice systems: Identifying opportunities for interventionOrienting patients to greater opioid safety: models of community pharmacy-based naloxone.Opioid overdose and naloxone education in a substance use disorder treatment program.Opiate addiction and overdose: experiences, attitudes, and appetite for community naloxone provision.Awareness of state legislation on naloxone accessibility associated with willingness to prescribe naloxone.Internal medicine resident knowledge, attitudes, and barriers to naloxone prescription in hospital and clinic settings.Public Perspectives on Expanding Naloxone Access to Reverse Opioid Overdoses.Medical providers' knowledge and concerns about opioid overdose education and take-home naloxone rescue kits within Veterans Affairs health care medical treatment settings.Group Visits for Overdose Education and Naloxone Distribution in Primary Care: A Pilot Quality Improvement Initiative.Can naloxone prescription and overdose training for opioid users work in family practice?: Perspectives of family physicians.
P2860
Q30727000-9AFE3845-7BAD-4566-9FFB-777520B57CBAQ30824524-A85D4542-E4AA-45F7-B088-EBFEE8211807Q35751870-7B05B80A-55AB-4755-B2BF-7F366843A598Q35882669-100D4E74-E3BC-4B5C-9026-D7B5E97EF096Q35923351-C6153344-F218-4AD8-9308-708568110610Q37352258-C2AAC249-A9AD-448F-BD2B-36113DABE55DQ38936820-EB54A135-05A3-450D-A803-E808B0F5B6D5Q39447890-23CD25BE-85DF-4D42-9B90-FDEA1C344529Q40049367-D65F2280-92C1-4FF9-A11E-DDF3C1564A94Q44339635-B1FCE07A-F189-4252-8054-741E5A4013DFQ44345493-2094653A-C3C3-4414-B706-BCDECDD449DEQ45070402-655CA47D-84BF-40A3-9AB2-882FCF1C30A2Q46136819-8E7F3D63-B325-42E1-BA6A-E9F20429CBB2
P2860
Barriers to medical provider support for prescription naloxone as overdose antidote for lay responders.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Barriers to medical provider s ...... e antidote for lay responders.
@en
Barriers to medical provider s ...... e antidote for lay responders.
@nl
type
label
Barriers to medical provider s ...... e antidote for lay responders.
@en
Barriers to medical provider s ...... e antidote for lay responders.
@nl
prefLabel
Barriers to medical provider s ...... e antidote for lay responders.
@en
Barriers to medical provider s ...... e antidote for lay responders.
@nl
P2093
P2860
P1476
Barriers to medical provider s ...... e antidote for lay responders.
@en
P2093
Madeline Ray
Nickolas D Zaller
Patricia Case
Robert Heimer
Sarah E Bowman
Traci C Green
P2860
P304
P356
10.3109/10826084.2013.787099
P577
2013-05-01T00:00:00Z